FINANCIAL PROJECTION

Description USG MUSKULOSKLETAL

Q'ty 1 Purchase on
UOM Unit Depreciation
Price 800,000,000 Dep. Value
Tax 88,000,000 12
Total Price 888,000,000 25

Description Per Treatment 1

2024
Treatment Average Per Day 1
Treatment Average Per Month 27 28
Treatment Average per Year 324 252
Growth 3% per Year 5%
REVENUE
Price 2,250,000 2,250,000
Price Increment 3.19%
Pasien Tunai 5.0% 29,250,000
Pasien Jaminan 95.0% 537,750,000
Price -
Price Increment 0.00%
Pasien BPJS 0.0% -
TOTAL REVENUE 567,000,000
-
COGS
Doctor's Fee
Pasien Tunai
Doctor fee 40.0% 11,700,000
Insentive nurse 2.0% 585,000
Pasien Jaminan
Doctor fee 40.0% 215,100,000
Insentive nurse 1.8% 9,679,500
Pasien BPJS
 Doctor fee 0% -
Insentive nurse 1.5% -
Total Doctor's Fee 237,064,500
Total Doctor's Fee (%) 41.81%

COGS HPP
Drugs
Inflation 3.19%
Consumables Increment 10% - -
Consumables -
Total Cost HPP -
Total Cost HPP (%) 0.00%

COGS Others
Referral Fee
% Basis
Repair & Maintenance 2% 3,489,100 3,489,000
Inflation 3.19%
Total COGS Others 3,489,000
Total COGS Others (%) 0.62%
Total COGS 240,553,500
Total COGS (%) 42.43%

Gross Margin 326,446,500

Gross Margin (%) 57.57%

OPERATING EXPENSES
Head 1 1
Cost Increment 8.1900%
Cost per Head 5,000,000 5,000,000
Manpower 45,000,000
% Manpower 7.94%
Management 40,560,534
% Management 20.44% PL YTD Jun 2023 7.15%
Operational Expenses 35,607,581
% Operational Expenses 6.28% PL YTD Jun 2023 6.28%
Total Operating Expenses 121,168,115
Total Operating Expenses (%) 21.37%

EBITDA 205,278,385
EBITDA (%) 36.20%
BREAK EVENT POINT BEP

Depreciation 83,250,000
Depreciation (%) 14.68%

EBIT (888,000,000) 122,028,385

EBIT (%) 21.52%

Tax 22% 26,846,245

EAT 95,182,140
EAT (%) 16.79%
Add back (83,250,000)
(888,000,000) 178,432,140
Accumulation 178,432,140
PAYBACK PERIOD NOT YET

CONSUMABLES
350,000 per Tindakan
 r

- - per Tindakan

AMENITIES

- - per Tindakan
 FINANCIAL INDICATOR
Discount Rate 7.2% %
Mar-24 (Year) As a 1st yea Break Even Point 1 Year
8 Year Payback Period 4 Year
111,000,000 /Year IRR 17.2% %
9,250,000 /Month NPV 803,442,762 IDR
370,000 /Day ROI 90.5% %

2 3 4 5 6
2025 2026 2027 2028 2029
1 1 1 1 1
29 30 31 32 33
348 360 372 384 396
3% 3% 3% 3% 3%

2,322,000 2,396,000 2,472,000 2,551,000 2,632,000

3.19% 3.19% 3.19% 3.19% 3.19%
39,474,000 43,128,000 46,968,000 48,469,000 52,640,000
768,582,000 819,432,000 872,616,000 931,115,000 989,632,000
- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%
- - - - -
808,056,000 862,560,000 919,584,000 979,584,000 1,042,272,000
- - - - -

15,789,600 17,251,200 18,787,200 19,387,600 21,056,000

789,480 862,560 939,360 969,380 1,052,800

307,432,800 327,772,800 349,046,400 372,446,000 395,852,800

13,834,476 14,749,776 15,707,088 16,760,070 17,813,376
 - - - - -
- - - - -
337,846,356 360,636,336 384,480,048 409,563,050 435,774,976
41.81% 41.81% 41.81% 41.81% 41.81%

3.19% 3.19% 3.19% 3.19% 3.19%

- - - - -
- - - - -
- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%

3,600,000 3,715,000 3,834,000 3,956,000 4,082,000

3.19% 3.19% 3.19% 3.19% 3.19%
3,600,000 3,715,000 3,834,000 3,956,000 4,082,000
0.45% 0.43% 0.42% 0.40% 0.39%
341,446,356 364,351,336 388,314,048 413,519,050 439,856,976
42.26% 42.24% 42.23% 42.21% 42.20%

466,609,644 498,208,664 531,269,952 566,064,950 602,415,024

57.74% 57.76% 57.77% 57.79% 57.80%

1 1 1 1 1
8.19% 8.19% 8.19% 8.19% 8.19%
5,409,500 5,852,538 6,331,861 6,850,440 7,411,491
64,914,000 70,230,456 75,982,332 82,205,280 88,937,892
8.03% 8.14% 8.26% 8.39% 8.53%
57,804,556 61,703,517 65,782,748 70,074,868 74,559,275
7.15% 7.15% 7.15% 7.15% 7.15%
50,745,890 54,168,740 57,749,845 61,517,843 65,454,648
 6.28% 6.28% 6.28% 6.28% 6.28%
173,464,446 186,102,713 199,514,925 213,797,991 228,951,815
21.47% 21.58% 21.70% 21.83% 21.97%

293,145,198 312,105,951 331,755,027 352,266,959 373,463,209

36.28% 36.18% 36.08% 35.96% 35.83%
BEP BEP BEP BEP BEP

111,000,000 111,000,000 111,000,000 111,000,000 111,000,000

13.74% 12.87% 12.07% 11.33% 10.65%

182,145,198 201,105,951 220,755,027 241,266,959 262,463,209

22.54% 23.32% 24.01% 24.63% 25.18%

40,071,944 44,243,309 48,566,106 53,078,731 57,741,906

142,073,254 156,862,642 172,188,921 188,188,228 204,721,303

17.58% 18.19% 18.72% 19.21% 19.64%
(111,000,000) (111,000,000) (111,000,000) (111,000,000) (111,000,000)
253,073,254 267,862,642 283,188,921 299,188,228 315,721,303
431,505,395 699,368,037 982,556,958 1,281,745,186 1,597,466,489
NOT YET NOT YET PAYBACK PAYBACK PAYBACK
 7 8 9 10
2030 2031 2032 2033
1 1 1 -
34 35 36 36
408 420 108 -
3% 3% 3% 0%

2,716,000 2,803,000 2,892,000 2,892,000

3.19% 3.19% 3.19% 0.00%
54,320,000 58,863,000 14,460,000 -
1,053,808,000 1,118,397,000 297,876,000 -
- - - -
0.00% 0.00% 0.00% 0.00%
- - - -
1,108,128,000 1,177,260,000 312,336,000 -
- - - -

21,728,000 23,545,200 5,784,000 -

1,086,400 1,177,260 289,200 -

421,523,200 447,358,800 119,150,400 -

18,968,544 20,131,146 5,361,768 -
 - - - -
- - - -
463,306,144 492,212,406 130,585,368 -
41.81% 41.81% 41.81% 0.00%

3.19% 3.19% 3.19% 0.00%

- - - -
- - - -
- - - -
0.00% 0.00% 0.00% 0.00%

4,212,000 4,346,000 4,485,000 -

3.19% 3.19% 3.19% 0.00%
4,212,000 4,346,000 4,485,000 -
0.38% 0.37% 1.44% 0.00%
467,518,144 496,558,406 135,070,368 -
42.19% 42.18% 43.25% 0.00%

640,609,856 680,701,594 177,265,632 -

57.81% 57.82% 56.75% 0.00%

1 1 1 1
8.19% 8.19% 8.19% 0.00%
8,018,492 8,675,206 9,385,705 9,385,705
96,221,904 104,102,472 28,157,115 -
8.68% 8.84% 9.02% 0.00%
79,270,306 84,215,687 22,343,060 -
7.15% 7.15% 7.15% 0.00%
69,590,402 73,931,890 19,614,691 -
 6.28% 6.28% 6.28% 0.00%
245,082,612 262,250,049 70,114,866 -
22.12% 22.28% 22.45% 0.00%

395,527,244 418,451,545 107,150,766 -

35.69% 35.54% 34.31% 0.00%
BEP BEP BEP BEP

111,000,000 111,000,000 27,750,000 -

10.02% 9.43% 8.88% 0.00%

284,527,244 307,451,545 79,400,766 -

25.68% 26.12% 25.42% 0.00%

62,595,994 67,639,340 17,468,169 -

221,931,250 239,812,205 61,932,597 -

20.03% 20.37% 19.83% 0.00%
(111,000,000) (111,000,000) (27,750,000) -
332,931,250 350,812,205 89,682,597 -
1,930,397,739 2,281,209,944 2,370,892,542 2,370,892,542
PAYBACK PAYBACK PAYBACK PAYBACK
 11 12 13 14 15
2034 2035 2036 2037 2038
- - - - -
36 36 36 36 36
- - - - -
0% 0% 0% 0% 0%

2,892,000 2,892,000 2,892,000 2,892,000 2,892,000

0.00% 0.00% 0.00% 0.00% 0.00%
- - - - -
- - - - -
- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%
- - - - -
- - - - -
- - - - -

- - - - -
- - - - -

- - - - -
- - - - -
 - - - - -
- - - - -
- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00%

- - - - -
- - - - -
- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%

- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%
- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%
- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%

- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%

1 1 1 1 1
0.00% 0.00% 0.00% 0.00% 0.00%
9,385,705 9,385,705 9,385,705 9,385,705 9,385,705
- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%
- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%
- - - - -
 0.00% 0.00% 0.00% 0.00% 0.00%
- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%

- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%
BEP BEP BEP BEP BEP

- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%

- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%

- - - - -

- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%
- - - - -
- - - - -
2,370,892,542 2,370,892,542 2,370,892,542 2,370,892,542 2,370,892,542
PAYBACK PAYBACK PAYBACK PAYBACK PAYBACK
 16 17 18 19 20
2039 2040 2041 2042 2043
- - - - -
36 36 36 36 36
- - - - -
0% 0% 0% 0% 0%

2,892,000 2,892,000 2,892,000 2,892,000 2,892,000

0.00% 0.00% 0.00% 0.00% 0.00%
- - - - -
- - - - -
- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%
- - - - -
- - - - -
- - - - -

- - - - -
- - - - -

- - - - -
- - - - -
 - - - - -
- - - - -
- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00%

- - - - -
- - - - -
- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%

- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%
- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%
- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%

- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%

1 1 1 1 1
0.00% 0.00% 0.00% 0.00% 0.00%
9,385,705 9,385,705 9,385,705 9,385,705 9,385,705
- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%
- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%
- - - - -
 0.00% 0.00% 0.00% 0.00% 0.00%
- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%

- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%
BEP BEP BEP BEP BEP

- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%

- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%

- - - - -

- - - - -
0.00% 0.00% 0.00% 0.00% 0.00%
- - - - -
- - - - -
2,370,892,542 2,370,892,542 2,370,892,542 2,370,892,542 2,370,892,542
PAYBACK PAYBACK PAYBACK PAYBACK PAYBACK
Assumption
 FORM PENGAJUAN ALAT MEDIS
USG MUSKULOSKLETAL

PROJECTS DESCRIPTION FINANCIAL

A Personal A Investment
1 Name 1 Estimated cost Rp 888,000,000
2 Others (if any) 2 Instalation cost
3 Others cost
B Division / Department Total cost Rp 888,000,000
1 Division
2 Department B Assumption
3 Group spesialis 1 Increased volume / year 3%
2 Increased price / year 3.19%
C Person in charge 3
1 Name
C Financial projection
D Requester 1 Billing's name Endoskopi Mix
1 Name 2 Price Rp 2,250,000
3 Hospital's portion Rp 1,350,000
E Competitor 4 Doctor's portion Rp 900,000
1 Name 5 Material cost (if any) Rp -
Price
2 Name Year 1 Year 2
Price Patients / month (avg) 28 29
3 Name Patients / year (avg) (Py) 252 348
Price
Revenue 567,000,000 808,056,000
F Others / Note : Doctor's Fee 237,064,500 337,846,356
COGS 3,489,000 3,600,000

Gross Margin (GM) 326,446,500 466,609,644

OPEX 121,168,115 173,464,446
EBITDA 205,278,385 293,145,198
EBITDA (%) 36.20% 36.28%
∑ EBITDA (accumulation) 205,278,385 498,423,583
G Level of Confidence
A Low Financial Indicator
B Medium BEP : 1 Year
C High IRR : 17% NPV : 803,442,762
ROI : 90% Pay Back Periode :

Hospital Approval

____________ , _____ - _____ - _______

Requester Division Head
 Expert Approval
(Recommendation Attached)

Corporate Approval

Reviewed by Approved by Approved by

Div. Financial Div Penunjang Medis Direktuir RS

EXPERT RECOMMENDATION

Investment : Expert Name : ______________________

Hospital Unit : Expert Specialty : ______________________
Desire Month :

Recommendation Note :

____________ , _____ - _____ - _______

Expert
 NGAJUAN ALAT MEDIS
MUSKULOSKLETAL

FINANCIAL PLANNING

A Timeline
1 Procurement Maret 2024
2 Instalation
3 Comercial use

B Business value to hospital / community

1
2
3
C Human / others resources
1
2
3

D Risk / mitigation
1
2
(DALAM RUPIAH) 3
Year 3 Year 4 Year 8
30 31 32 E Supplier (company, PIC, Phone number)
360 372 384 1
2
862,560,000 919,584,000 979,584,000 3
360,636,336 384,480,048 409,563,050
3,715,000 3,834,000 3,956,000

498,208,664 531,269,952 566,064,950 Formula (Financial) :

186,102,713 199,514,925 213,797,991 1 Revenue = Price X Patients per year
312,105,951 331,755,027 352,266,959 2 Doctor's Fee = Revenue X Doctor's Fee
36.18% 36.08% 35.96% 3 COGS = COGS X Patients per year
810,529,534 1,142,284,561 1,494,551,520 4 Gross margin = Revenue - Doctor's Fee -
COGS
5 EBITDA = Gross Margin - OPEX
6 Depreciation = Total Investment /
803,442,762 Depreciation Year
4 year

Hospital Approval

Approved by
n Head Division KAP Hospital Director
Expert Approval
mmendation Attached)

orporate Approval

ed by Approved by Approved by

___________
___________
PT INDO HUSADA UTAMA
RSU ABDUL RADJAK HOSPITAL

LAPORAN LABA RUGI

DESCRIPTION 2024 2025 2026 2027

REVENUE 567 808 863 920

REVENUE COVID - - - -
REVENUE BPJS - - - -
REVENUE 567 808 863 920
% KMK Revenue 0% 0% 0% 0%
% BPJS Revenue 0% 0% 0% 0%

DISCOUNT - - - -
DISCOUNT BPJS - - - -
DISCOUNT REVENUE - - - -
% to Net Revenue 0% 0% 0% 0%
% BPJS Disc to BPJS Revenue 0% 0% 0% 0%

NET REVENUE 567 808 863 920

% BPJS Revenue 0% 0% 0% 0%

FEE DOKTER 237 338 361 384

% to Net Revenue 42% 42% 42% 42%

COGS HPP - - - -
% to Net Revenue 0% 0% 0% 0%

COGS Lain2 3 4 4 4
% to Net Revenue 1% 0% 0% 0%

TOTAL COGS 241 341 364 388

% to Net Revenue 42% 42% 42% 42%

GROSS MARGIN 326 467 498 531

% to Net Revenue 58% 58% 58% 58%

SDM 86 123 132 142

% to Net Revenue 15% 15% 15% 15%

OPEX 36 51 54 58
% to Net Revenue 6% 6% 6% 6%

TOTAL OPERATING EXP. 121 173 186 200

 % to Net Revenue 21% 21% 22% 22%

EBITDA 205 293 312 332

% to Net Revenue 36% 36% 36% 36%

DEPRECIATION 83 111 111 111

% to Net Revenue 15% 14% 13% 12%

EBIT 122 182 201 221

% to Net Revenue 22% 23% 23% 24%

OTHER INCOME & EXPENSES - - - -

% to Net Revenue 0% 0% 0% 0%

TAX 27 40 44 49
% to Net Revenue 5% 5% 5% 5%

PROFIT (LOSS) 95 142 157 172

% to Net Revenue 17% 18% 18% 19%

PROFIT (LOSS) per Tindakan 0.378 0.408 0.436 0.463

2028 2029 2030 2031 2032 2033 2034

980 1,042 1,108 1,177 312 - -

- - - - - - -
- - - - - - -
980 1,042 1,108 1,177 312 - -
0% 0% 0% 0% 0% 0% 0%
0% 0% 0% 0% 0% 0% 0%

- - - - - - -
- - - - - - -
- - - - - - -
0% 0% 0% 0% 0% 0% 0%
0% 0% 0% 0% 0% 0% 0%

980 1,042 1,108 1,177 312 - -

0% 0% 0% 0% 0% 0% 0%

410 436 463 492 131 - -

42% 42% 42% 42% 42% 0% 0%

- - - - - - -
0% 0% 0% 0% 0% 0% 0%

4 4 4 4 4 - -
0% 0% 0% 0% 1% 0% 0%

414 440 468 497 135 - -

42% 42% 42% 42% 43% 0% 0%

566 602 641 681 177 - -

58% 58% 58% 58% 57% 0% 0%

152 163 175 188 51 - -

16% 16% 16% 16% 16% 0% 0%

62 65 70 74 20 - -
6% 6% 6% 6% 6% 0% 0%

214 229 245 262 70 - -

22% 22% 22% 22% 22% 0% 0%

352 373 396 418 107 - -

36% 36% 36% 36% 34% 0% 0%

111 111 111 111 28 - -

11% 11% 10% 9% 9% 0% 0%

241 262 285 307 79 - -

25% 25% 26% 26% 25% 0% 0%

- - - - - - -
0% 0% 0% 0% 0% 0% 0%

53 58 63 68 17 - -
5% 6% 6% 6% 6% 0% 0%

188 205 222 240 62 - -

19% 20% 20% 20% 20% 0% 0%

0.490 0.517 0.544 0.571 0.573 - -

2043

-
-
-
-
0%
0%

-
-
-
0%
0%

-
0%

-
0%

-
0%

-
0%

-
0%

-
0%

-
0%

-
0%

-
0%

-
0%

-
0%

-
0%

-
0%

-
0%

-
0%